Submitted abstracts
Orals
O-001 - Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors

https://doi.org/10.1093/annonc/mdy149Get rights and content
Under an Elsevier user license
open archive

Cited by (0)